NCCTG N057K phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: A North Central Cancer Treatment Group trial.

被引：0
|
作者：
Ma, Daniel
Galanis, Evanthia
Schiff, David
Wu, Wenting
Peller, Patrick J.
Giannini, Caterina
Brown, Paul D.
Uhm, Joon H.
McGraw, Steven
Jaeckle, Kurt A.
Flynn, Patrick J.
Buckner, Jan C.
Sarkaria, Jann Nagina
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Univ Virginia, Med Ctr, Charlottesville, VA USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Sioux Community Canc Consortium, Sioux Falls, SD USA
[5] Mayo Clin, Jacksonville, FL 32224 USA
[6] Metro Minnesota Community Clin Oncol Project, St Louis Pk, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2031
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Final results of glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
    Salgado, M. A. Vaz
    del Barco, S.
    Sepulveda, J. M.
    Alonso, M.
    Pineda, E.
    Balana, C.
    Martinez-Garcia, M.
    Girones, R.
    Lopez-Munoz, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S410 - S410
  • [22] Safety and efficacy of glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
    Vaz, Maria Angeles
    Girones, Regina
    Del Barco, Sonia
    Sanchez, Juan Manuel Sepulveda
    Alonso, Miriam
    Pineda, Estela
    Balana, Carmen
    Martinez-Garcia, Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [23] PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Chen, Changhu
    Damek, Denise
    Gaspar, Laurie E.
    Ney, Douglas
    Waziri, Allen
    Lillehei, Kevin
    Kavanagh, Brian D.
    NEURO-ONCOLOGY, 2011, 13 : 128 - 128
  • [24] PHASE I/II TRIAL OF RADIATION THERAPY, TEMOZOLOMIDE AND PEMBROLIZUMAB FOLLOWED BY TEMOZOLOMIDE AND PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Dixit, Karan
    Kumthekar, Priya
    Kruser, Timothy
    Bloch, Orin
    Chandler, James
    Tate, Matthew
    Raizer, Jeffrey
    NEURO-ONCOLOGY, 2016, 18 : 19 - 19
  • [25] Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial
    Perez-Larraya, Jaime Gallego
    Ducray, Francois
    Chinot, Olivier
    Catry-Thomas, Isabelle
    Taillandier, Luc
    Guillamo, Jean-Sebastien
    Campello, Chantal
    Monjour, Annick
    Cartalat-Carel, Stephanie
    Barrie, Maryline
    Huchet, Aymeri
    Beauchesne, Patrick
    Matta, Mona
    Mokhtari, Karima
    Tanguy, Marie-Laure
    Honnorat, Jerome
    Delattre, Jean-Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (22) : 3050 - 3055
  • [26] AVAglio: Phase 3 Trial of Bevacizumab Plus Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
    Chinot, O. L.
    Rouge, T. de la Motte
    Moore, N.
    Zeaiter, A.
    Das, A.
    Phillips, H.
    Modrusan, Z.
    Cloughesy, T.
    ADVANCES IN THERAPY, 2011, 28 (04) : 334 - 340
  • [27] AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
    O. L. Chinot
    T. de La Motte Rouge
    N. Moore
    A. Zeaiter
    A. Das
    H. Phillips
    Z. Modrusan
    T. Cloughesy
    Advances in Therapy, 2011, 28 : 334 - 340
  • [28] AVAglio: A phase III trial of bevacizumab added to standard radiotherapy and temozolomide in patients with newly diagnosed glioblastoma.
    Chinot, O. L.
    Wick, W.
    Saran, F.
    Mason, W. P.
    Henriksson, R.
    Nishikawa, R.
    Zeaiter, A. H.
    Moore, N.
    Das, A.
    Cloughesy, T. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [29] A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Saran, Frank
    James, Allan
    McBain, Catherine
    Jefferies, Sarah
    Harris, Fiona
    Cseh, Agnieszka
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Brada, Michael
    NEURO-ONCOLOGY, 2018, 20 : 20 - 20
  • [30] Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03
    Herrlinger, Ulrich
    Rieger, Johannes
    Koch, Dorothee
    Loeser, Simon
    Blaschke, Britta
    Kortmann, Rolf-Dieter
    Steinbach, Joachim P.
    Hundsberger, Thomas
    Wick, Wolfgang
    Meyermann, Richard
    Tan, Ta-Chih
    Sommer, Clemens
    Bamberg, Michael
    Reifenberger, Guido
    Weller, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4412 - 4417
12345